{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:05:29Z","timestamp":1790960729542,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":691,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.immuni.2022.05.018","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T02:30:28Z","timestamp":1653618628000},"page":"1316-1326.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants"],"prefix":"10.1016","volume":"55","author":[{"given":"Marios","family":"Koutsakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Shi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Reynaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyon-Xhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Gare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwee Chin","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Taiaroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cromer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Juno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles P.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2022.05.018_bib1","doi-asserted-by":"crossref","first-page":"2200042","DOI":"10.2807\/1560-7917.ES.2022.27.6.2200042","article-title":"Shorter serial intervals in SARS-CoV-2 cases with Omicron BA.1 variant compared with Delta variant, the Netherlands, 13 to 26 December 2021","volume":"27","author":"Backer","year":"2022","journal-title":"Euro Surveill."},{"key":"10.1016\/j.immuni.2022.05.018_bib2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.05.018_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","article-title":"Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron","volume":"602","author":"Carre\u00f1o","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.05.018_bib4","doi-asserted-by":"crossref","first-page":"e00310","DOI":"10.1128\/JCM.00310-20","article-title":"Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp\/Hel real-time reverse transcription-PCR assay validated in\u00a0vitro and with clinical specimens","volume":"58","author":"Chan","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.immuni.2022.05.018_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19","volume":"384","author":"Chen","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib6","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.cmi.2021.11.010","article-title":"Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicenter cohort study","volume":"28","author":"Chia","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.immuni.2022.05.018_bib7","doi-asserted-by":"crossref","first-page":"n1943","DOI":"10.1136\/bmj.n1943","article-title":"Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study","volume":"374","author":"Chung","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.immuni.2022.05.018_bib8","doi-asserted-by":"crossref","first-page":"2000045","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill"},{"key":"10.1016\/j.immuni.2022.05.018_bib9","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.immuni.2022.05.018_bib10","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ni.3533","article-title":"Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination","volume":"17","author":"Ellebedy","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2022.05.018_bib11","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1016\/j.vaccine.2021.05.011","article-title":"Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research","volume":"39","author":"Ferdinands","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.05.018_bib12","doi-asserted-by":"crossref","first-page":"eabi4547","DOI":"10.1126\/scitranslmed.abi4547","article-title":"Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates","volume":"13","author":"Francica","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib13","first-page":"113.e15","article-title":"Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques is coincident with anamnestic antibody response in the lung","volume":"185","author":"Gagne","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2022.05.018_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.05.018_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from Covid-19","volume":"384","author":"Joyner","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib16","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41591-020-0995-0","article-title":"Humoral and circulating follicular helper T\u00a0cell responses in recovered patients with COVID-19","volume":"26","author":"Juno","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib17","article-title":"Immunity in Omicron SARS-CoV-2 breakthrough COVID-19 in vaccinated adults","author":"Kared","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.immuni.2022.05.018_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib19","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMc2102507","article-title":"Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated persons","volume":"385","author":"Kissler","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/JLB.5MR0821-464R","article-title":"T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination","volume":"111","author":"Koutsakos","year":"2022","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.immuni.2022.05.018_bib21","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41467-021-23018-x","article-title":"Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients","volume":"12","author":"Nguyen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.05.018_bib22","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2022.05.018_bib23","doi-asserted-by":"crossref","first-page":"e715","DOI":"10.1016\/S2666-5247(21)00180-4","article-title":"Immune-mediated attenuation of influenza illness after infection: opportunities and challenges","volume":"2","author":"Patel","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.immuni.2022.05.018_bib24","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1172\/JCI137265","article-title":"Landscape of coordinated immune responses to H1N1 challenge in humans","volume":"130","author":"Rahil","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2022.05.018_bib25","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.immuni.2022.05.018_bib26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1056\/NEJMc2119236","article-title":"SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals","volume":"386","author":"Roessler","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T\u00a0cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.05.018_bib28","article-title":"Virological characteristics of SARS-CoV-2 vaccine breakthrough infections in health care workers","author":"Shamier","year":"2021","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.immuni.2022.05.018_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(21)00648-4","article-title":"Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study","volume":"22","author":"Singanayagam","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.immuni.2022.05.018_bib30","article-title":"Determinants of passive antibody effectiveness in SARS-CoV-2 infection","author":"Stadler","year":"2022","journal-title":"Preprint at medRxiv"},{"key":"10.1016\/j.immuni.2022.05.018_bib31","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41591-021-01583-4","article-title":"BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar","volume":"27","author":"Tang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib32","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2021.19499","article-title":"Association between mRNA vaccination and COVID-19 hospitalization and disease severity","volume":"326","author":"Tenforde","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.immuni.2022.05.018_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.05.018_bib35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41467-021-21444-5","article-title":"Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19","volume":"12","author":"Wheatley","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.05.018_bib36","doi-asserted-by":"crossref","first-page":"109822","DOI":"10.1016\/j.celrep.2021.109822","article-title":"Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain","volume":"37","author":"Wheatley","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2022.05.018_bib34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41590-022-01175-5","article-title":"Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T\u00a0cell memory","volume":"23","author":"Wragg","year":"2022","journal-title":"Nat. Immunol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:16:44Z","timestamp":1761034604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761322002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1074761322002382"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2022.05.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742167698.793593338","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.23.21268285","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2022.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}